Table 3.
Univariate and multivariate Cox regression analyses for disease-free survival in patients with gastric cancer.
| Clinicopathologic features | Total (n=142) | Median | Univariate analysis | Multivariate analysis | |||
|---|---|---|---|---|---|---|---|
| (months) | P | HR (95% CI) | P | HR (95% CI) | |||
| HBV statue | 0.000 | 2.13 (1.55-3.21) | 0.000 | 2.19 (1.49-3.21) | |||
| Positive | 71 | 16.67 | |||||
| Negative | 71 | 33.00 | |||||
| Gender | 0.299 | 1.24 (0.83-1.86) | 0.540 | 1.14 (0.75-1.75) | |||
| Male | 103 | 19.5 | |||||
| Female | 39 | 26.6 | |||||
| Age | 0.092 | 1.36 (0.95-1.94) | 0.350 | 1.20 (o.82-1.78) | |||
| <62 | 69 | 22.47 | |||||
| ≧62 | 73 | 18.7 | |||||
| TNM | 0.216 | 1.34 (0.84-2.14) | 0.774 | 1.07 (0.66-1.77/ | |||
| I-II | 25 | 26.7 | |||||
| III-IV | 117 | 19.5 | |||||
| Histological grade | 0.059 | 1.15 (0.95-1.76) | 0.839 | 0.95 (0.61-1.50) | |||
| G1-G2 | 28 | 27.27 | |||||
| G3 | 114 | 20.77 | |||||
DFS, disease free survival; CI, confidence interval; HR, hazard ratios; HBV positive ,positive for HBsAg or anti-HBs, anti-HBe, and anti-HBc; HBV negative, negative for HBsAg, HBeAg, anti-HBe, anti-HBs, and anti-HBc; TNM, tumor, lymph node, metastasis.
Bold values indicate statistically significant difference.